13.59
price down icon0.80%   -0.11
 
loading

Finanzdaten der Evolus Inc-Aktie (EOLS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
21.95%
61.00
50.02 49.35 41.72 43.65
Cost Of Revenue
24.88%
19.27
15.43 14.71 12.15 13.37
Gross Profit
20.65%
41.73
34.59 34.63 29.57 30.28
Operating Expenses
4.86%
50.36
48.03 49.75 41.62 40.91
Interest Income/Expense
7.63%
4.075
3.786 3.182 2.789 2.631
Benefits Costs and Expenses
8.68%
72.72
66.92 67.46 56.49 56.75
Costs And Expenses
9.73%
69.63
63.46 64.46 53.76 54.28
Operating Income/Loss
35.75%
-8.635
-13.44 -15.12 -12.04 -10.64
Income/Loss From Continuing Operations Before Tax
30.62%
-11.72
-16.90 -18.12 -14.77 -13.11
Income Tax Expense/Benefit, Deferred
0.005
- - - -0.003
Income Tax Expense/Benefit
341.67%
0.106
0.024 0.023 0.023 0.057
Income/Loss From Continuing Operations After Tax
30.09%
-11.83
-16.92 -18.14 -14.79 -13.16
Net Income/Loss
30.09%
-11.83
-16.92 -18.14 -14.79 -13.16
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.81%
0.1104
57.02 56.92 56.48 0.0678
Diluted Average Shares
99.81%
0.1104
57.02 56.92 56.48 0.0678
Basic Earnings Per Share
33.33%
-0.20
-0.30 -0.32 -0.26 -0.24
Diluted Earnings Per Share
33.33%
-0.20
-0.30 -0.32 -0.26 -0.24
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$65.00
price down icon 2.30%
$17.19
price up icon 1.24%
$55.37
price up icon 0.22%
drug_manufacturers_specialty_generic RDY
$68.26
price down icon 1.50%
$10.98
price down icon 0.36%
$142.29
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):